Page last updated: 2024-08-22

n-isopropylacrylamide and Angiogenesis, Pathologic

n-isopropylacrylamide has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ariizumi, S; Asai, T; Egami, H; Hamashima, Y; Hoshino, Y; Ide, T; Kanazawa, H; Koide, H; Miura, Y; Nishimura, Y; Okishima, A; Oku, N; Shea, KJ; Yoshimatsu, K	1

Other Studies

1 other study(ies) available for n-isopropylacrylamide and Angiogenesis, Pathologic

Article	Year
Sequestering and inhibiting a vascular endothelial growth factor in vivo by systemic administration of a synthetic polymer nanoparticle. Journal of controlled release : official journal of the Controlled Release Society, 2019, 02-10, Volume: 295 Topics: Acrylamides; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A	2019

Article

Year

Sequestering and inhibiting a vascular endothelial growth factor in vivo by systemic administration of a synthetic polymer nanoparticle.

Journal of controlled release : official journal of the Controlled Release Society, 2019, 02-10, Volume: 295

Topics: Acrylamides; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A

2019